Potassium Chloride Extended Release NDC 70010-021

NDC codes

FDA NDC Directory

Product NDC (as listed)70010-021Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70010-0021Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70010-021-01	70010002101	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-021-01)Marketed from Oct 22, 2020
70010-021-05	70010002105	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-021-05)Marketed from Oct 22, 2020
70010-021-10	70010002110	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-021-10)Marketed from May 4, 2021
70010-021-61	70010002161	3 BLISTER PACK in 1 CARTON (70010-021-61) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Jan 3, 2022
70010-021-62	70010002162	10 BLISTER PACK in 1 CARTON (70010-021-62) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Jan 3, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Chloride Extended Release
Generic name (nonproprietary): potassium chloride
Active ingredients: Potassium chloride — 600 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Granules Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211797
Marketing start: Oct 22, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 70010-021_f33d5a34-e5e7-a85f-e053-2995a90a6db3SPL ID f33d5a34-e5e7-a85f-e053-2995a90a6db3SPL set ID 9f8d2886-9ecd-4cbf-a84a-2d221cb3497cRxCUI 312529, 628953UNII 660YQ98I10
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470010002101 followed by a unit qualifier and the quantity

Package 70010-0021-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2023.

Indications (excerpt from the label)

Potassium chloride extended-release tablets are indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. Potassium chloride extended-release tablets are a potassium salt, indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)